69 Days
Source:
Financial Times
Novartis acquires UK biotech Myricx for $1.5bn
A cancer-focused company was established in 2019 through a spin-out from Imperial College and the Francis Crick Institute. The company's formation aimed to advance cancer research and treatment. Further details about its operations or developments are not provided.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)